SavedAdd your journal

Journals / Sakarya Tıp Dergisi / 2021 / Cilt: 11 - Sayı: 4

Retrospective Analysis of The Effect of Omega-3 Use on Hemodynamic and Biochemical Parameters in Patients with Acute Respiratory Distress Syndrome

Akut Solunum Sıkıntısı Sendromu Olan Hastalarda Omega-3 Kullanımının Hemodinamik ve Biyokimyasal Parametrelere Etkisinin Retrospektif Analizi

Sema KOÇAN
Leyla KAZANCIOĞLU
Yağmur DEMİREL
Canan ALTINSOY
Pages
816–822
Publication Date
2021-12-27
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

More research is needed to support the study findings.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study is; To examine the effect of omega-3 used in patients with ARDS on hemodynamic and biochemical parameters.
📊
Key Findings & Data:Materials and Methods: In the study, the records of ARDS patients over the age of 18 who received omega-3 support between January 2017 and January 2020 in the anesthesiology and reanimation intensive care unit of a training and research hospital were analyzed retrospectively.
💡
Conclusion & Impact:More research is needed to support the study findings.
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Akut solunum sıkıntısı sendromu · beslenme desteği · omega-3

Abstract

Objective: The aim of this study is; To examine the effect of omega-3 used in patients with ARDS on hemodynamic and biochemical parameters. Materials and Methods: In the study, the records of ARDS patients over the age of 18 who received omega-3 support between January 2017 and January 2020 in the anesthesiology and reanimation intensive care unit of a training and research hospital were analyzed retrospectively. Results: The median GCS score of the patients was 9.61 ± 4.36 and the median APACHE II score was 20.86 ± 9.22. The leukocyte value of the patients after taking omega-3 (9.69 ± 4.84) was statistically significantly lower than the leukocyte value (12.62 ± 7.01) before taking omega-3 (p = 0.000). Similarly, the CRP level (33.10 ± 48.15) of the patients after taking omega-3 was statistically significantly lower than the CRP level before taking omega-3 (63.08 ± 89.29) (p = 0.001). The prealbumin value (26.83 ± 5.04) of the patients after taking omega-3 was statistically significantly higher than the value before taking (25.40 ± 4.12) (p = 0.014). However, it was determined that the use of omega-3 did not create a statistically significant difference in hemoglobin values of the patients (p = 0.542). Conclusion: The use of omega-3 in patients with ARDS may be associated with improvement in some hemodynamic and biochemical parameters. More research is needed to support the study findings.

Özet

Amaç: Bu çalışmanın amacı; ARDS gelişen hastalarda kullanılan omega-3’ün hemodinamik ve biyokimyasal parametrelere etkisini incelemektir. Gereç ve Yöntem: Çalışmada, bir eğitim ve araştırma hastanesinin anesteziyoloji ve reanimasyon yoğun bakım ile cerrahi yoğun yakım ünitelerinde Ocak 2017-Ocak 2020 tarihleri arasında takip edilen 18 yaşından büyük, omega-3 desteği alan ARDS hastalarının kayıtları retrospektif olarak incelendi. Bulgular: Hastaların medyan GKS skoru 9,61±4,36 ve medyan APACHE II skoru 20,86±9,22 olarak bulundu. Hastaların omega-3 aldıktan sonraki lökosit değeri (9,69±4,84), almadan önceki lökosit değerine (12,62±7,01) göre istatistiksel olarak anlamlı düşüktü (p=0,000). Benzer şekilde hastaların omega-3 aldıktan sonraki CRP düzeyi (33,10±48,15), almadan önceki CRP düzeyine (63,08±89,29) göre istatistiksel olarak anlamlı düşüktü (p=0,001). Omega-3 aldıktan sonra hastaların prealbumin değeri (26,83±5,04), almadan önceki değere (25,40±4,12) göre istatistiksel olarak anlamlı yüksekti (p=0,014). Ancak omega-3 kullanımının hastaların hemoglobin değerinde istatistiksel olarak anlamlı bir farklılık oluşturmadığı belirlendi (p=0,542). Sonuç: ARDS gelişen hastalarda omega-3 kullanımı bazı hemodinamik ve biyokimyasal parametrelerde iyileşme ile ilişkilendirilebilir. Çalışma bulgularını desteklemek adına daha fazla araştırmaya ihtiyaç vardır.

🔖

Cite This Article

KOÇAN, S., KAZANCIOĞLU, L., DEMİREL, Y., ALTINSOY, C. (2021). Retrospective Analysis of The Effect of Omega-3 Use on Hemodynamic and Biochemical Parameters in Patients with Acute Respiratory Distress Syndrome. Sakarya Tıp Dergisi, Cilt: 11 - Sayı: 4, 816–822. https://ajindex.com/articles/395581

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Fan E, Brodie D, Slutsky AS. Acute respiratory distress syndrome: advances in diagnosis and treatment. Jama 2018;319(7):698-710
  2. Papazian L, Aubron C, Brochard L, Chiche J-D, Combes A, Dreyfuss D, et al. Formal guidelines: management of acute respiratory distress syndrome. Ann Intensive Care 2019;9(1):69
  3. Confalonieri M, Salton F, Fabiano F. Acute respiratory distress syndrome. European Respiratory Review 2017;26(144):1-7
  4. Artigas A, Carlet J, Le Gall J, Chastang C, Blanch L. Clinical presentation, prognostic factors, and outcome of ARDS in the European Collaborative Study (1985-1987). Lung biology in health and disease 1991;50:37-63
  5. Koçan S, Aktuğ C. Nefes alamıyorum: COVID-19 ve akut respiratuvar distress sendromu. İçinde: Gürsoy A (eds.), Cerrahi Hastalıkları Hemşireliği ve COVID-19
  6. Baskı. Ankara: Türkiye Klinikleri; 2020. s: 15-18
  7. Parish M, Valiyi F, Hamishehkar H, Sanaie S, Asghari Jafarabadi M, Golzari SE, et al. The Effect of Omega-3 Fatty Acids on ARDS: A Randomized Double-Blind Study. Adv Pharm Bull 2014;4(Suppl 2):555-561
  8. Gadek JE, DeMichele SJ, Karlstad MD, Pacht ER, Donahoe M, Albertson TE, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med 1999;27(8):1409-1420
  9. Calder P, Grimble R. Polyunsaturated fatty acids, inflammation and immunity. European journal of clinical nutrition 2002;56(3):14-19
  10. Calder PC. Polyunsaturated fatty acids, inflammation, and immunity. Lipids 2001;36(9):1007-1024
  11. Stapleton RD, Martin TR, Weiss NS, Crowley JJ, Gundel SJ, Nathens AB, et al. A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Critical care medicine 2011;39(7):1655
  12. Rice TW, Wheeler AP, Thompson BT, DeBoisblanc BP, Steingrub J, Rock P. Enteral omega-3 fatty acid, γ-linolenic acid, and antioxidant supplementation in acute lung injury. Jama 2011;306(14):1574-1581
  13. Çelik F, Edipoğlu İS. Yoğun Bakım Hastalarında Erken Enteral İmmünonütrisyon Uygulamasının Enflamatuvar Yanıta Etkisi. Turkish Journal of Intensive Care 2019;17(2): 88-95
  14. Turner KL, Moore FA, Martindale R. Nutrition support for the acute lung injury/adult respiratory distress syndrome patient: a review. Nutrition in Clinical Practice 2011;26(1):14-25
  15. Xu J, Pan T, Qi X, Tan R, Wang X, Liu Z, et al. Increased mortality of acute respira